Evidence
Use of β-blocker therapy in older patients after acute myocardial infarction in Ontario
Paula A. Rochon, Geoffrey M. Anderson, Jack V. Tu, Jocalyn P. Clark, Jerry H. Gurwitz, John Paul Szalai and Paula Lau
CMAJ November 30, 1999 161 (11) 1403-1408;
Paula A. Rochon
MD, MPH
Geoffrey M. Anderson
MD, PhD
Jack V. Tu
MD, PhD
Jocalyn P. Clark
MSc
Jerry H. Gurwitz
MD
John Paul Szalai
PhD
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Use of β-blocker therapy in older patients after acute myocardial infarction in Ontario
Paula A. Rochon, Geoffrey M. Anderson, Jack V. Tu, Jocalyn P. Clark, Jerry H. Gurwitz, John Paul Szalai, Paula Lau
CMAJ Nov 1999, 161 (11) 1403-1408;
Jump to section
Related Articles
Cited By...
- Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?
- Effects of {beta}-Blockers and Anxiety on Complication Rates After Acute Myocardial Infarction
- Integrating pharmacists into family practice teams: Physicians' perspectives on collaborative care
- Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction
- Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction
- Do patients' expectations influence their use of medications?: Qualitative study
- Resting Heart Rate in Cardiovascular Disease
- Outcomes and Optimal Antithrombotic Therapy in Women Undergoing Fibrinolysis for ST-Elevation Myocardial Infarction
- Corrections